Evidence map›Paper›PMID 23250953›Full record

ArticleInfection and immunity2013

Role of the NK cell-activating receptor CRACC in periodontitis.

Benjamin Krämer, Moritz Kebschull, Michael Nowak, Ryan T Demmer, Manuela Haupt, Christian Körner, Sven Perner, Søren Jepsen, Jacob Nattermann, Panos N Papapanou

Open access · hybridAbstract read
In one paragraph

Article in Infection and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Infectious and Immunological Links Between Periodontitis and COVID-19: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. The influence ofCentral-European journal of immunology · 2017
    Article
  14. Review
  15. Article
  16. Genome-Wide Analysis of Periodontal and Peri-Implant Cells and Tissues.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Benjamin KrämerDepartment of Medicine I, University of Bonn, Bonn, Germany.
Moritz Kebschull
Michael Nowak
Ryan T Demmer
Manuela Haupt
Christian Körner
Sven Perner
Søren Jepsen
Jacob Nattermann
Panos N Papapanou
University of Bonn · DEColumbia University · US

Funding

Gene Expression in Chronic and Aggressive PeriodontitisR01DE015649 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PAPAPANOU, PANOS N · 2004 to 2006
$1.8M
Periodontal Infections and Type 2 Diabetes Mellitus RiskR00DE018739 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEMMER, RYAN T. · 2010 to 2014
$783k
MicroRNA expression in gingival tissues in periodontal health and diseaseR21DE021820 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PAPAPANOU, PANOS N · 2012 to 2013
$432k
Periodontal Infections and Type 2 Diabetes Mellitus RiskK99DE018739 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEMMER, RYAN T. · 2008 to 2009
$180k
NIDCR NIH HHS DE-015649NIDCR NIH HHS DE-018739NIDCR NIH HHS DE-021820NIDCR NIH HHS K99 DE018739NIDCR NIH HHS R00 DE018739NIDCR NIH HHS R01 DE015649NIDCR NIH HHS R21 DE021820
6 · The paper itself

Abstract

Periodontitis is a highly prevalent, biofilm-mediated chronic inflammatory disease that results in the loss of the tooth-supporting tissues. It features two major clinical entities: chronic periodontitis, which is more common, and aggressive periodontitis, which usually has an early onset and a rapid progression. Natural killer (NK) cells are a distinct subgroup of lymphocytes that play a major role in the ability of the innate immune system to steer immune responses. NK cells are abundant in periodontitis lesions, and NK cell activation has been causally linked to periodontal tissue destruction. However, the exact mechanisms of their activation and their role in the pathophysiology of periodontitis are elusive. Here, we show that the predominant NK cell-activating molecule in periodontitis is CD2-like receptor activating cytotoxic cells (CRACC). We show that CRACC induction was significantly more pronounced in aggressive than chronic periodontitis and correlated positively with periodontal disease severity, subgingival levels of specific periodontal pathogens, and NK cell activation in vivo. We delineate how Aggregatibacter actinomycetemcomitans, an oral pathogen that is causally associated with aggressive periodontitis, indirectly induces CRACC on NK cells via activation of dendritic cells and subsequent interleukin 12 (IL-12) signaling. In contrast, we demonstrate that fimbriae from Porphyromonas gingivalis, a principal pathogen in chronic periodontitis, actively attenuate CRACC induction on NK cells. Our data suggest an involvement of CRACC-mediated NK cell activation in periodontal tissue destruction and point to a plausible distinction in the pathobiology of aggressive and chronic periodontitis that may help explain the accelerated tissue destruction in aggressive periodontitis.

Indexed as

Cells, CulturedFimbriae ProteinsGene Expression RegulationHumansKiller Cells, NaturalPasteurellaceaePeriodontitisReceptors, ImmunologicRNA, MessengerSignaling Lymphocytic Activation Molecule FamilyTranscriptomeUp-RegulationFimbriae ProteinsReceptors, ImmunologicRNA, MessengerSignaling Lymphocytic Activation Molecule FamilySLAMF7 protein, human

Identifiers

PMID23250953
PMCPMC3584889
OpenAlexW2162287209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.